Waters Corporation
As of Oct 22, 2026, Waters is in Stage 2, the uptrend phase, now in week 16 (since Jul 1, 2026). It closed at $455.59, 0.9% below its 52-week high and above its 200-day average, which is rising.
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 32 in Diagnostics & Research · #1 of 272 in Health Care
Is WAT early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
WAT among Diagnostics & Research14th of 44 by relative strength
All 44 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | CDNA | Stage 2 · wk 24 | 99 | +27.3% |
| 2 | BDSX | Stage 2 · wk 18 | 98 | −18.3% |
| 3 | ILMN | Stage 2 · wk 24 | 97 | +5.5% |
| 4 | GH | Stage 2 · wk 21 | 97 | −7.6% |
| 5 | NTRA | Stage 2 · wk 20 | 96 | +2.7% |
| 6 | CRL | Stage 2 · wk 16 | 92 | +22.5% |
| 7 | RVTY | Stage 2 · wk 18 | 90 | +10.7% |
| 8 | PSNL | Stage 2 · wk 17 | 90 | −3.2% |
| …14 | WAT | Stage 2 · wk 16 | 77 | +8.3% |
Waters: quick answers
What stage is Waters in?
As of Oct 22, 2026, Waters (WAT) is in Stage 2, the uptrend phase. It entered Stage 2 on Jul 1, 2026 and is in week 16. What the four stages mean
Is Waters in an uptrend?
Yes. Waters is in a Stage 2 uptrend. It trades 24.0% above its 200-day average, which is rising.
How far is Waters from its 52-week high?
Waters closed at $455.59 on Oct 22, 2026, 0.9% below its 52-week high of $459.93. Its 52-week low is $283.32.
How has Waters performed over the past year?
As of Oct 22, 2026, Waters is up 30.5% over the past year and up 19.3% so far in 2026.
Which sector and industry is Waters in?
Waters is in the Diagnostics & Research industry, part of the Health Care sector.
About this companyHealth Care· Diagnostics & Research
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.